Stacy Seng

Stacy Seng is an accomplished professional with a strong educational background and extensive experience in the healthcare and medical device industry.

She holds a Master of Business Administration (M.B.A.) from Harvard Business School, a Certificate of Completion from the Director's Consortium at Stanford University Graduate School of Business, and a Bachelor's Degree in Public Policy Analysis from Michigan State University.

Stacy currently serves as a Venture Partner at Lightstone Ventures and has held various key positions in several reputable organizations within the healthcare sector.

Her notable past roles include Independent Director at Vesper Medical, Inc., Chairwoman of the Board and Independent Director at Contego Medical, Inc., Independent Director at LivaNova, and Chairwoman of the Board and Independent Director at Cala Health.

She has also served as an Independent Director at Precardia, Inc., Fogarty Institute for Innovation, Hill-Rom, Sonova Group, Claret Medical, Spirox, Inc., and Director at Solace Therapeutics.

Stacy brings a wealth of experience to the table, having held leadership positions such as President, Vascular at Covidien, President, Peripheral Vascular at ev3, Vice President of Cardiovascular Marketing at Boston Scientific, and Director of Marketing at Boston Scientific.

Her career journey also includes roles such as New Modalities Marketing at Scimed, Product Manager at Baxter International Inc., and Sales Representative at American Hospital Supply.

With her diverse background and expertise in the medical device and healthcare industry, Stacy Seng continues to make a significant impact in her field.